NCT01687400View on ClinicalTrials.gov

Genomic Predictors of Decitabine Response in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndromes

PHASE2CompletedINTERVENTIONAL
Enrollment

114

Participants

Timeline

Start Date

February 12, 2013

Primary Completion Date

June 23, 2017

Study Completion Date

November 13, 2017

Conditions
Leukemia, Myeloid, AcuteMyelodysplastic Syndromes
Interventions
DRUG

decitabine

Trial Locations (1)

63110

Washington University School of Medicine, St Louis

All Listed Sponsors
lead

Washington University School of Medicine

OTHER

NCT01687400 - Genomic Predictors of Decitabine Response in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndromes | Biotech Hunter | Biotech Hunter